In Vitro Activities of Moxifloxacin and Other Fluoroquinolones against Mycoplasma pneumoniae
A total of 105 isolates of Mycoplasma pneumoniae were evaluated for susceptibility to moxifloxacin, sparfloxacin, levofloxacin, and ciprofloxacin. Moxifloxacin, a newly synthesized compound, showed the greatest activity. The MICs and MBCs at which 50 and 90% of isolates were affected were 0.15 (MIC(...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2001
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90571/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353651/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1908-1910.2001 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
